Assessment Subjective Nararamdaman ko din na nanghihina ako at para banf palage ako walang lakasVerbalized by patient Objective Decrease

e urine output 25cc/hr Decrease oral fluid intake(400-500ml) PoorSkinturgor Pale nail beds Pale palpebral Conjunctiva Slightly pale nasal and buccal mucosa Dry and Cracked lips Thready/weak pulse

Nursing Diagnosis Fluid volume deficit related to acive fluid volume loss (diarrhea)

Planning Short term goal After 1-2hours of nursing intervention, the clent will maintain adequate fluid volume loss through fluid hydration and monitoring of intake and output Long term goal After 8 hours of nursing intervention,the client will have an increase in energy levels and prevent further complication as evidence by patients verbalization of an increase energy level

Intervention Encourage client to increase oral fluid intake Provide meticulous oral care Check voiding and record amount Promote a quiet environment and bed rest Regularl assess client for changes in conditions Strictly monitor I/O

Evaluation Short term goal After 1-2 hours of nursing intervention,the client maintained adequate fluid volume versus active fluid loss as evidenced by an increase in oral fluid intake from 500 ml to 1000ml with moistened mucous membrane,good skin turgor and increase urine output of 30cc/hr-goal partially met Long term goal After 8 hours of nursing intervention.,the client reported a slight increase in energy level and absence of complication as verbalized by the patient. -goal partially met.

Therapeutic Classification Metronidazole Classification: Antipotozoal

Action is selectively absorbed by anaerobic bacteria and sensitive protozoa. Once taken up by anaerobes, it is non-enzymatically reduced by reacting with reduced ferredoxin, which is generated by pyruvate oxidoreductase. Many of the reduced nitroso intermediates will form sulfinamides and thioether linkages with cysteine-bearing enzymes, thereby deactivating these critical enzymes.

Contraindication Check with your physician if you have any of the following: Conditions: Alcohol Intoxication, Lower Seizure Threshold, Any Disorder of the Brain, Numbness, Tingling or Pain of Hands or Feet, Meningitis Not Caused by an Infection, Severe Liver Disease, Seizures, Decreased Neutrophils a Type of White Blood Cell, Habit of Drinking Too Much Alcohol Allergies: NITROIMIDAZOLES

Toxicity Effect
Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention. Check with your doctor immediately if any of the following side effects occur: More common Agitation Back pain Blindness Changes in speech patterns Depression Dizziness Drowsiness Eye pain Fever Hallucinations Headache Irritability Lack of coordination Mood or mental changes Nausea Seizures Shakiness and unsteady walk Slurred speech Stiff neck or back Trouble speaking

Indications
Amebiasis. Flagyl (metronidazole) is indicated in the treatment of acute intestinal amebiasis (amebic dysentery) and amebic liver abscess. In amebic liver abscess, Flagyl (metronidazole) therapy does not obviate the need for aspiration or drainage of pus. Anaerobic Bacterial Infections. Flagyl (metronidazole) is indicated in the treatment of serious infections caused by susceptible anaerobic bacteria. Indicated surgical procedures should be performed in conjunction with Flagyl (metronidazole) therapy. In a mixed aerobic and anaerobic infection, antimicrobials appropriate for the treatment of the aerobic infection should be used in addition to Flagyl (metronidazole) .

Safety Dosage For amebiasis infections: Adults and teenagers500 or 750 milligrams (mg) 3 times per day for 5 to 10 days. ChildrenDose is based on body weight and must be determined by your doctor. The dose is usually 35 to 50 milligrams (mg) per kilogram (kg) of body weight per day, divided and given in 3 doses, for 10 days.

Cefuroxime Classification Antibiotic

Inhibits synthesis of bacterial cell wall, causing cell death

An allergic reaction (difficulty breathing; closing of the throat; swelling of the lips, face, or tongue; hives; or a rash). Rash, redness or itching. Severe nausea, vomiting, or diarrhea

CNS : Headache,dizziness, lethargy,paresthesias GI : Nausea, vomiting, diarrhea, anorexia, abdominal pain, flatulence, pseudomembranous colitis, liver toxicity Hematologic : Bone marrow depression:decreased WBC, decreased platelets, decreased Hct GU : Nephrotoxicity Hypersensitivity :Ranging from rash to fever to anaphylaxis, serum sickness reaction Other :Super infections,disulfiramlike reaction with alcohol

For dermatologic infections, caused by S.aureus, S. pyogenes Fights bacteria in the body. Is used to treat many different types of bacterial infections.

750mg TIV q 8

Assessment Subjective napansin ko na hindi normal ang laki ng ulo ng anak ko verbalized by mother Objective REstlessnesss Irritability Changes in vital signs V/S Taken as follow T=37.5 P=90 R=22

Nursing Diagnosis Ineefective cerebral tissue perfusion related to arterial or venous blood flow

Planning After 8 hours of nursing intervention the patient will demonstrate improved vital signs and absence of signs of increased ICP

Intervention Monitor temperature.Administer TSB in presence of fever. Monitor Intake/Output Maintained head or neck in midline or in neutral position Provide rest periods between care of activities and limit duration of procedures Decrease extraneous stimuli and provide comfort measures as back massafe,quiet environment genile touch. Help patient avoid or limit coughing,cring vomiting and straigning of stool Elevate The Head of bed gradually to 15-30 degress as tolerated or indicated Administer diuretics as indicated

Evaluation After 8 hours of nursing intervention.the patient was able to demonstrate improved vital signs of increase icp

Therapeutic Classification Ampicillin Classification Systemic Antiinfectives

Action Inhibits bacterial cell wall synthesis by binding to one or more of the penicillin binding proteins (PBPs); which in turn inhibits the final transpeptidation step of peptidoglycan synthesis in bacterial cell walls, thus inhibiting cell wall biosynthesis. Bacteria eventually lyse due to ongoing activity of cell wall autolytic enzymes (autolysins and murein hydrolases) while cell wall assembly is arrested.

Contraindication Hypersensitivity to penicillins. Infectious mononucleosis. Use cautiously with renal disorders.

Toxicity Effect
Call your doctor at once if you have a serious side effect such as:

Indication Treatment of UTI, otitis media, sinusitis,bronchitis, uncomplicated community-acquired pneumonia,Haemophil us influenzae infections and invasives almonellosis

Safety dosage
Usual Pediatric Dose for Bacterial Endocarditis Prophylaxis Low to moderate risk: 50 mg/kg IV or IM 30 minutes before procedure. High risk: 50 mg/kg plus gentamicin 1.5 mg/kg, both intramuscularly or IV 30 minutes before procedure. Follow with ampicillin 25 mg/kg IV or IM, or amoxicillin 25 mg/kg orally, 6 hours after initial dose. Usual Pediatric Dose for Meningitis Neonates: < 7 days, birthweight < 2000 g: 50 mg/kg IV every 12 hours. < 7 days, birthweight > 2000 g: 50 mg/kg IV every 8 hours. > 7 days, birthweight < 1200 g: 50 mg/kg IV every 12 hours. > 7 days, birthweight 1200 to 2000 g: 50 mg/kg IV every 8 hours. > 7 days, birthweight > 2000 g: 50 mg/kg IV every 6 hours. Infants and children: 50 to 100 mg/kg IV every 6 hours. Maximum dose 12

fever, sore throat, and headache with a severe blistering, peeling, and red skin rash; diarrhea that is watery or bloody; fever, chills, body aches, flu symptoms; easy bruising or bleeding, unusual weakness; urinating less than usual or not at all; agitation, confusion, unusual thoughts or behavior; or seizure (blackout or convulsions).

g/day. Ampicillin should be given in combination with another antibiotic, depending on the nature of the infection. Usual Pediatric Dose for Skin or Soft Tissue Infection IV: 6.25 to 12.5 mg/kg every 6 hours (maximum 12 g/day). Oral: 6.25 to 12.5 mg/kg every 6 hours (maximum 2 to 3 g/day).

Mannitol Classification Diuretics

Increases osmotic pressure of plasma in glomerular filtrate, inhibiting tubularre absorption of water and electrolytes (including sodium and potassium). These actions enhance water flow from various tissues and ultimately decrease intracranial and intraocular pressures; serum sodium level rises while potassium and blood urea levels fall .Also protects kidneys by preventing toxins from forming and blocking tubules

Active intracranial bleeding (except during craniotomy) Anuria secondary to severe renal disease Progressive heart failure, pulmonary congestion, renal damage, or renaldysfunctio n after mannitol therapy begins Severe pulmonary congestion or pulmonary edema

To reduce intracranial pressure and brain mass Test dose for marked oliguria or suspected inadequate renal function To prevent oliguria during cardiovascular and other surgeries Acute oliguria To reduce intraocular pressure To promote diuresis in drug toxicity Irrigation during transurethral resection of prostate (TURP)

0.5 to 2 g/kg IV infusion as15% to 25% solution given over 30 to60 minutesMannitol (Osmitrol) 150cc IV q8

Severe dehydration